Treats pain associated with true trigeminal neuralgia. ANDA 75712, held by Torrent Pharms. Carbamazepine.
As of Nov 16, 2026, ANDA 75712 (Carbamazepine), held by Torrent Pharms, was first approved by FDA on Jul 5, 2001, with 18 approved supplements and 0 published complete response letters.
INDICATIONS AND USAGE Epilepsy Carbamazepine is indicated for use as an anticonvulsant drug. Evidence supporting efficacy of carbamazepine as an anticonvulsant was derived from active drug-controlled studies that enrolled patients with the following seizure types: 1. Partial seizures with complex symptomatology (psychomotor, temporal lobe). Patients with these seizures appear to show greater improvement than those with other types. 2. Generalized tonic-clonic seizures (grand mal). 3. Mixed seizure patterns which include the above, or other partial or generalized seizures. Absence seizures (petit mal) do not appear to be controlled by carbamazepine (see PRECAUTIONS, General ).
| Date | Submission | Status | Documents |
|---|---|---|---|
| Jul 5, 2001 | Original application | Approved | None posted |
| Product | Active ingredient | Marketing |
|---|---|---|
| Carbamazepine100MG · tablet, chewable;oral | Carbamazepine | Rx |
| Mar 20, 2026 | Supplement 39Labeling · Standard review | Approved | None posted |
| Jan 27, 2025 | Supplement 36Labeling · Standard review | Approved | None posted |
| Mar 3, 2021 | Supplement 29Labeling · Standard review | Approved | None posted |
| Mar 3, 2021 | Supplement 32Labeling · Standard review | Approved | None posted |
| Jan 20, 2015 | Supplement 26Labeling · Standard review | Approved | None posted |
| Jan 20, 2015 | Supplement 27Labeling · Standard review | Approved | None posted |
| Feb 19, 2014 | Supplement 23Labeling · Standard review | Approved | None posted |
| Feb 19, 2014 | Supplement 24Labeling · Standard review | Approved | None posted |
| Jun 19, 2012 | Supplement 22Labeling · Standard review | Approved | None posted |
| Sep 27, 2011 | Supplement 18Labeling | Approved | None posted |
| May 27, 2010 | Supplement 15Labeling | Approved | None posted |
| Feb 23, 2010 | Supplement 14Labeling | Approved | None posted |
| Feb 23, 2010 | Supplement 16Labeling | Approved | None posted |
| Feb 11, 2008 | Supplement 10Labeling | Approved | None posted |
| Dec 17, 2007 | Supplement 9Labeling | Approved | None posted |
| Oct 1, 2002 | Supplement 2Manufacturing | Approved | None posted |
| Oct 1, 2002 | Supplement 3Labeling | Approved | None posted |
| Oct 25, 2001 | Supplement 1Manufacturing | Approved | None posted |
| Jul 5, 2001 | Original application | Approved | None posted |
Approvals, supplements, products and documents come from FDA's Drugs@FDA data files, refreshed daily; Drugs@FDA lists approved applications only. Complete response letters are FDA's published letters. Drugs@FDA and FDA complete response letters